Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study

BACKGROUND: Corona Virus Disease 2019 (COVID-19) due to the 2019 novel coronavirus (SARS-CoV-2) emerged in Wuhan city and rapidly spread throughout China. We aimed to compare arbidol and lopinavir/ritonavir(LPV/r) treatment for patients with COVID-19 with LPV/r only. METHODS: In this retrospective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Lisi, Li, Chunna, Zeng, Qi, Liu, Xi, Li, Xinghua, Zhang, Haitang, Hong, Zhongsi, Xia, Jinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156152/
https://www.ncbi.nlm.nih.gov/pubmed/32171872
http://dx.doi.org/10.1016/j.jinf.2020.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156152/
https://www.ncbi.nlm.nih.gov/pubmed/32171872
http://dx.doi.org/10.1016/j.jinf.2020.03.002

Ejemplares similares